Home Newsletters Umbilical & Placental Cell News Preclinical Assessment of Thrombin-Preconditioned Human Wharton’s Jelly-Derived Mesenchymal Stem Cells for Neonatal...

Preclinical Assessment of Thrombin-Preconditioned Human Wharton’s Jelly-Derived Mesenchymal Stem Cells for Neonatal Hypoxic-Ischaemic Brain Injury

0
The authors evaluated the tissue distribution and potential toxicity of thrombin-preconditioned human Wharton’s jelly-derived MSCs in animal models before the initiation of clinical trials.
[Journal of Cellular and Molecular Medicine]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version